-
The stock price has broken out from the consolidation which held for last three weeks
-
Volumes during the breakout has seen sharp jump
-
The stock has seen long build of more than 5% in Derivative segment on 14th Jan 2021
-
Higher tops and higher bottoms on the daily and weekly charts
-
The price is also placed above all important moving average parameters
-
Indicators and oscillators have turned bullish
-
We recommend buying Cadila Healthcare Jan 510 Call at 20 for the upside target of 30, keeping Stoploss at 15.
==========================
Disclaimer: Vinay Rajani is Senior Technical and Derivative Research Analyst at HDFC Securities. The analyst doesn't have any holding in the stock. Views are personal.